Freedom of Information request on 1. The full list of ingredients in the Comirnaty 10 micrograms/dose concentrate for dispersion for injection COVID-19 mRNA Vaccine (nucleoside modified) (PLGB 53632/0006) - (FOI 22/571)
Published 1 June 2022
© Crown copyright 2022
This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gov.uk.
Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
This publication is available at https://www.gov.uk/government/publications/freedom-of-information-responses-from-the-mhra-week-commencing-21-march-2022/freedom-of-information-request-on-1the-full-list-of-ingredients-in-the-comirnaty-10-microgramsdose-concentrate-for-dispersion-for-injection-covid-1
FOI 22/571
25th March 2022
Dear
Thank you for your email.
Please find below answers to the questions you have raised.
- The full list of ingredients in the Comirnaty 10 micrograms/dose concentrate for dispersion for injection COVID-19 mRNA Vaccine (nucleoside modified) (PLGB 53632/0006) is available in the SmPC from the MHRA website. A link to this is provided below:
https://mhraproducts4853.blob.core.windows.net/docs/3fa3caca6abf5080e37500abc7b9790223ad8e76
- Comirnaty 10 micrograms/dose concentrate for dispersion for injection COVID-19 mRNA Vaccine (nucleoside modified) (PLGB 53632/0006) is authorised for active immunisation to prevent COVID-19 caused by SARS-CoV-2 virus in children aged 5 to 11 years. This product is authorised via a reliance procedure following a European Commission (EC) decision. Further information, including the Public Assessment Report (PAR), is available from the European Medicines Agency (EMA). A link to this information is provided below:
https://www.ema.europa.eu/en/medicines/human/EPAR/comirnaty
Yours sincerely
MHRA Customer Experience Centre
Medicines and Healthcare products Regulatory Agency
10 South Colonnade, Canary Wharf, London E14 4PU
Telephone 0203 080 6000